Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Clinical Investigation

• Publication date

  1989-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI114037PMID 2708519PMCID PMC303846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts

  2004cited by this paper
• Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.

  1988cited by this paper
• Radioimmunotherapy of human colon carcinoma by 131I‐labelled monoclonal anti‐cea antibodies in a nude mouse model

  1988cited by this paper
• Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.

  1988cited by this paper
• Use of second antibody in radioimmunotherapy.

  1987cited by this paper
• Therapeutic application of radiolabeled monoclonal antibody UJ13A in children with disseminated neuroblastoma.

  1987cited by this paper
• Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs.

  1987cited by this paper
• Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

  1987cited by this paper
• Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.

  1987cited by this paper
• Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.

  1987cited by this paper
• Treatment of a Patient with b Cell Lymphoma by 1-131 Lym-1 Monoclonal Antibodies

  1987cited by this paper
• Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts.

  1987cited by this paper
• In Vitro and In Vivo Tumor Models for Studies of Distribution of Radiolabelled Monoclonal Antibodies and Fragments

  1986cited by this paper
• Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.

  1986cited by this paper
• Improved radioimmunolocalization of carcinomas using Fab fragments with anti-CEA specificity.

  1986cited by this paper
• Characterization of a new monoclonal antibody to a cell surface antigen on colorectal cancer and fetal gut tissues

  1986cited by this paper
• Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.

  1986cited by this paper
• BONE MARROW TRANSPLANTATION WITH T‐CELL-DEPLETED GRAFTS

  1986cited by this paper
• Preparation of F(ab')2 fragments from mouse IgG of various subclasses.

  1986cited by this paper
• Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.

  1986cited by this paper
• Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow grafts.

  1986cited by this paper
• Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.

  1986cited by this paper
• Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy.

  1986cited by this paper
• Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.

  1985cited by this paper
• Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: Tumoricidal effects and distribution studies

  1985cited by this paper
• Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.

  1985cited by this paper
• Intratumor localization of monoclonal antibody in patients with melanoma treated with antibody to a 250,000-dalton melanoma-associated antigen.

  1985cited by this paper
• Inflammatory tumor response to monoclonal antibody infusion.

  1985cited by this paper
• Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma.

  1985cited by this paper
• Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model.

  1984cited by this paper
• Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.

  1984cited by this paper
• Monoclonal antibodies identify a cea crossreacting antigen of 95 kD (NCA‐95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD

  1984cited by this paper
• Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.

  1984cited by this paper
• Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration.

  1984cited by this paper
• EFFECT OF SIZE OF RADIOLABELED ANTIBODY AND FRAGMENTS ON TUMOR UPTAKE AND DISTRIBUTION IN NEPHRECTOMIZED MICE

  1984cited by this paper
• Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

  1983cited by this paper
• Radioimmunodetection of human tumor xenografts by monoclonal antibodies.

  1983cited by this paper
• Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice

  1983cited by this paper
• Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.

  1983cited by this paper
• Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.

  1983cited by this paper
• Preparation of F(ab')2 fragments from mouse IgG of various subclasses.

  1983cited by this paper
• IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

  1982cited by this paper
• Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

  1982cited by this paper
• Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.

  1981cited by this paper
• Experimental radioimmunotherapy of a xenografted human colonic tumor (GW-39) producing carcinoembryonic antigen.

  1981cited by this paper
• Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.

  1980cited by this paper
• Colorectal carcinoma antigens detected by hybridoma antibodies

  1979cited by this paper
• Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

  1979cited by this paper
• Isolation and characterization of carcinoembryonic antigen (CEA) extracted from normal human colon mucosa.

  1977cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice

  1974cited by this paper
• Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein.

  1972cited by this paper

• Radioimmunotherapy

  2020cites this paper
• Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases

  2017cites this paper
• [Recombinant Monoclonal Antibodies, from Tumor Targeting to Cancer Immunotherapy: A Critical Overview].

  2017cites this paper
• Recombinant Monoclonal Antibodies, from Tumor Targeting to Cancer Immunotherapy: A Critical Overview

  2017cites this paper
• Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases.

  2017cites this paper
• Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting &agr;‐particles or Auger electrons☆

  2017cites this paper
• Nanoparticle and Targeted Systems for Colon Cancer Therapy

  2016cites this paper
• Antibody-Targeted Therapeutic Radionuclides in the Management of Colorectal Cancer

  2013cites this paper
• Pretargeting: Advancing the Delivery of Radionuclides

  2013cites this paper
• Introduction to monoclonal antibodies.

  2012cites this paper
• Tumours: Targeting of Monoclonal Antibodies for Imaging and Potential for Therapy

  2012cites this paper
• Treatment of transplanted tumor of lung adenocarcinoma A549 transfected by human somatostatin receptor subtype 2 (hsstr2) gene with 188Re-RC-160.

  2010cites this paper
• Les anticorps radiomarqués pour le traitement des cancers

  2009cites this paper
• Les anticorps radiomarqués le traitement des cancers

  2009cites this paper
• [Radiolabeled antibodies for cancer treatment].

  2009cites this paper
• Recombinant IgA Antibodies

  2007cites this paper
• Carcinoembryonic Antigen Specificity and Affinity of Monoclonal Antibodies against Updated

  2006cites this paper
• Fractionated Radiotherapy of Human Colon Cancer Liver Metastases in Nude Mice 1

  2006cites this paper
• Radioimmunotherapy of carcinoma of colon with [131I]- labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen

  2005cites this paper
• Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers

  2004cites this paper
• Tumours: Targeting of Monoclonal Antibodies for Imaging and Potential for Therapy

  2002cites this paper
• Targeted therapy of cancer with radiolabeled antibodies.

  2002influential citation
• Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.

  2001cites this paper
• Radioimmunotherapy of Colorectal Cancer Liver Metastases: Combination with Radiotherapy

  2000cites this paper
• Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study.

  2000cites this paper
• Diagnostic and therapeutic evaluation of an anti-Langerhans cell histiocytosis monoclonal antibody (NA1/34) in a new xenograft model.

  2000cites this paper
• Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.

  1999cites this paper
• Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.

  1999cites this paper
• An anti‐CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)‐mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells

  1998cites this paper
• Long circulating half‐life and high tumor selectivity of the photosensitizer meta‐tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma

  1998cites this paper
• Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.

  1998cites this paper
• Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.

  1997cites this paper
• Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice.

  1997cites this paper
• Selection of radioimmunoconjugates for the therapy of well‐established or micrometastatic colon carcinoma

  1997cites this paper
• Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: A model for radioimmunotherapy

  1996cites this paper
• Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN‐14 F(ab)2

  1996cites this paper
• Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibody F(ab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice.

  1996cites this paper
• Immunophotodetection of Cancer by Antibody-Indocyanin Conjugates

  1996cites this paper
• Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

  1996cites this paper
• Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion?

  1995cites this paper
• Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma.

  1995cites this paper
• Biodistribution of monoclonal antibody Po66 in a human lung tumour-bearing mouse model: effect of blood exchange on tumour antibody uptake.

  1995cites this paper
• Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.

  1995cites this paper
• Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66.

  1995cites this paper
• Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.

  1995cites this paper
• Therapeutic Antibodies to Tumours

  1995cites this paper
• Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.

  1994cites this paper
• The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

  1994cites this paper
• Comparative tumor localization of whole immunoglobulin g anticarcinoembryonic antigen monoclonal antibodies immu‐4 and immu‐4 f(ab′)2 in colorectal cancer patients

  1994cites this paper
• Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?

  1994cites this paper
• Dimeric recombinant IgA directed against carcino-embryonic antigen, a novel tool for carcinoma localization.

  1994cites this paper
• Prospects for Cancer Imaging and Therapy with Radioimmunoconjugates

  1994cites this paper
• Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.

  1993cites this paper
• Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues.

  1993cites this paper
• Sensitivity and specificity of Gold types 1 to 5 anti-carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues.

  1993cites this paper
• Experimental radioimmunotherapy.

  1993cites this paper
• Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.

  1993influential citation
• Chimeric CEA-Specific Antibody Fragments and Anti-idiotypic Antibodies for Immunoscintigraphy and New Therapeutic Approaches to Colorectal Carcinomas

  1993cites this paper
• Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor.

  1993cites this paper
• Radioimmunotherapy: clinical results and dosimetric considerations.

  1992cites this paper
• Diminution of antibodies directed against tumor cell surface epitopes: a single chain Fv fusion molecule specifically recognizes the extracellular domain of the c-erbB-2 receptor.

  1992cites this paper
• Monoclonal Antibody Administration

  1992cites this paper
• Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen.

  1992influential citation
• Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

  1992cites this paper
• Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.

  1992cites this paper
• Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo

  1992cites this paper
• A monoclonal anti‐idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen

  1992cites this paper
• Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppression.

  1992cites this paper
• Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats

  1992cites this paper
• Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen.

  1992cites this paper
• Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.

  1992cites this paper
• Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments.

  1991cites this paper
• Suppression of Tumor Vascular Activity by Radioantibody Therapy: Implications for Multiple Cycle Treatments

  1991cites this paper
• Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice.

  1991cites this paper
• The effect of radiosensitizers on radio‐immunotherapy, using 131I‐Labelled anti‐cea antibodies in a human colonic xenograft model

  1991cites this paper
• Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.

  1991cites this paper
• Antibody–fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice

  1991cites this paper
• Radioimmunolocalization of human colonic cancer xenografts; aspects of extensive purification of monoclonal anti-CEA-antibodies.

  1991cites this paper
• Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors.

  1991cites this paper
• Antibodytargetedtherapyincancer:comparisonof murineandclinicalstudies

  1990cites this paper
• Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.

  1990cites this paper
• Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

  1990cites this paper
• F(ab')2 fragments versus intact antibody--an isodose comparison.

  1990cites this paper
• Antibody targeted therapy in cancer: comparison of murine and clinical studies.

  1990cites this paper
• Current perspectives and challenges in the use of monoclonal antibodies as imaging and therapeutic agents

  1990cites this paper
• Generation of a recombinant mouse‐human chimaeric monoclonal antibody directed against human carcinoembryonic antigen

  1989cites this paper
• Imaging of colorectal carcinoma with radiolabeled antibodies.

  1989cites this paper